Comparative Study: Long-Term Neurodevelopmental Outcomes in Neonates Treated with Lacosamide vs Other Antiseizure Medications for Neonatal Seizures

Study identification

• EU PAS number:
  EUPAS1000000618
• Study ID:
  1000000618
• Official title and acronym:
  Comparative Study: Long-Term Neurodevelopmental Outcomes in Neonates Treated with Lacosamide vs Other Antiseizure Medications for Neonatal Seizures
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

No information provided.

Study timelines

Date when funding contract was signed

Actual:15/05/2025

Study start date

Planned:16/06/2025

Actual:17/06/2025

Date of final study report

Planned:15/02/2026

Actual:18/02/2026

Sources of funding

More details on funding

UCB Biopharma SRL

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

EP0223